Variant report
Variant | esv3354044 |
---|---|
Chromosome Location | chr2:50245898-50248196 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:33)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:33 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:50246112-50246411 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr2:50246112-50246386 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr2:50245918-50246489 | Hela-S3 | cervix: | n/a | n/a |
4 | CHD2 | chr2:50246157-50246357 | Hela-S3 | cervix: | n/a | n/a |
5 | E2F4 | chr2:50246109-50246340 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | EP300 | chr2:50246059-50246447 | Hela-S3 | cervix: | n/a | chr2:50246254-50246268 |
7 | FOS | chr2:50245946-50246474 | MCF10A-Er-Src | breast: | n/a | chr2:50246199-50246211 |
8 | FOS | chr2:50246004-50246475 | MCF10A-Er-Src | breast: | n/a | chr2:50246199-50246211 |
9 | FOS | chr2:50246060-50246463 | MCF10A-Er-Src | breast: | n/a | chr2:50246199-50246211 |
10 | FOS | chr2:50246040-50246476 | MCF10A-Er-Src | breast: | n/a | chr2:50246199-50246211 |
11 | JUN | chr2:50246151-50246351 | H1-hESC | embryonic stem cell: | n/a | chr2:50246254-50246267 chr2:50246199-50246211 chr2:50246239-50246252 |
12 | JUN | chr2:50246107-50246425 | Hela-S3 | cervix: | n/a | chr2:50246254-50246267 chr2:50246199-50246211 chr2:50246239-50246252 |
13 | JUN | chr2:50246109-50246397 | HepG2 | liver: | n/a | chr2:50246254-50246267 chr2:50246199-50246211 chr2:50246239-50246252 |
14 | JUND | chr2:50246095-50246413 | HepG2 | liver: | n/a | chr2:50246199-50246211 |
15 | JUND | chr2:50246175-50246440 | H1-hESC | embryonic stem cell: | n/a | chr2:50246199-50246211 |
16 | JUND | chr2:50246092-50246407 | Hela-S3 | cervix: | n/a | chr2:50246199-50246211 |
17 | KAP1 | chr2:50245328-50246485 | U2OS | brain: | n/a | n/a |
18 | MAX | chr2:50246105-50246368 | Hela-S3 | cervix: | n/a | chr2:50246256-50246265 |
19 | MYC | chr2:50246075-50246353 | MCF10A-Er-Src | breast: | n/a | chr2:50246256-50246265 |
20 | MYC | chr2:50246073-50246360 | MCF10A-Er-Src | breast: | n/a | chr2:50246256-50246265 |
21 | POLR2A | chr2:50247797-50248119 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | PRDM1 | chr2:50246077-50246320 | Hela-S3 | cervix: | n/a | chr2:50246206-50246221 |
23 | RCOR1 | chr2:50246132-50246333 | Hela-S3 | cervix: | n/a | n/a |
24 | RFX5 | chr2:50246156-50246332 | Hela-S3 | cervix: | n/a | n/a |
25 | SETDB1 | chr2:50245869-50246628 | U2OS | brain: | n/a | n/a |
26 | SMC3 | chr2:50246164-50246377 | Hela-S3 | cervix: | n/a | n/a |
27 | STAT3 | chr2:50245955-50246405 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr2:50246135-50246416 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | STAT3 | chr2:50245975-50246442 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | STAT3 | chr2:50245931-50246399 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | STAT3 | chr2:50245957-50246385 | Hela-S3 | cervix: | n/a | n/a |
32 | TCF7L2 | chr2:50246089-50246379 | Hela-S3 | cervix: | n/a | n/a |
33 | USF2 | chr2:50246245-50246445 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NRXN1 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534952608 | chr2:50245907-50245908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553296142 | chr2:50245987-50245988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375590034 | chr2:50246017-50246018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566128269 | chr2:50246027-50246028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536257468 | chr2:50246091-50246092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554909607 | chr2:50246123-50246124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544711052 | chr2:50246182-50246183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140183289 | chr2:50246205-50246206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543871159 | chr2:50246214-50246215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7571903 | chr2:50246224-50246225 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs146211469 | chr2:50246233-50246234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373856264 | chr2:50246235-50246236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7586095 | chr2:50246249-50246250 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs377305326 | chr2:50246272-50246273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529880973 | chr2:50246299-50246300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541371609 | chr2:50246361-50246362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559621729 | chr2:50246370-50246371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79131040 | chr2:50246400-50246401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs80238440 | chr2:50246402-50246403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184290934 | chr2:50246408-50246409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541473137 | chr2:50246548-50246549 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs553318000 | chr2:50247825-50247826 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs145559178 | chr2:50247892-50247893 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs6754803 | chr2:50247942-50247943 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs558216565 | chr2:50247990-50247991 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs527909664 | chr2:50248008-50248009 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs548057581 | chr2:50248016-50248017 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs557631787 | chr2:50248035-50248036 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50242600-50246000 | Enhancers | Brain Germinal Matrix | brain |
2 | chr2:50244000-50246200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr2:50244600-50246600 | Enhancers | Hela-S3 | cervix |
4 | chr2:50245000-50246000 | Enhancers | Brain Substantia Nigra | brain |
5 | chr2:50245400-50246000 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr2:50245400-50246000 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr2:50245400-50246000 | Enhancers | Fetal Brain Female | brain |
8 | chr2:50245400-50246400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:50245600-50246000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:50245600-50246000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr2:50245600-50246400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr2:50245600-50246400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr2:50245800-50246200 | Enhancers | HUES64 Cell Line | embryonic stem cell |